TCL Archive In Brief: After Nickles Removes Block, Senate Confirms Oncologist Henney As FDA Commissioner October 23, 1998
TCL Archive NCI Plans $175 Million In Program Cuts To Cover Deficit, Fund New Initiatives November 17, 2006
TCL Archive Over Half of ALK-Positive NSCLC Patients Responded To Crizotinib In Colorado Study November 26, 2010
TCL Archive Troubles of Two Landmark Cancer Drugs, Celebrex and Iressa, Likely to Shape cancer Prevention, FDA Policy. FDA Mulls Withdrawal of Iressa. January 7, 2005
